# Phentermine: Why It Often Comes Before a GLP-1

> Dr. Collin Bennett on phentermine: who it's for, who shouldn't take it, side effects, the evidence, and why insurers often require it before a GLP-1.

Source: https://www.collinbennett.com/note-phentermine  
Peak Health, PLLC (Colorado Springs, CO) is not open yet and is not seeing patients. To hear first, join the waitlist at https://www.collinbennett.com/#waitlist. General education, not medical advice.

---

Health note

# Phentermine: what it is, who it's for, and why it often comes first

If your insurance asked you to try phentermine before covering a GLP-1, here's why, and what to know before you start.

Written by [Collin R. Bennett, MD](https://www.collinbennett.com/about), board-certified family physician. Updated November 17, 2026.

The short answer

- Many insurance plans, including TRICARE plans, won't cover Wegovy or Zepbound until you've tried a cheaper medicine such as phentermine for about 3 months, unless you have a reason not to take it.
- Phentermine is an inexpensive, once-daily appetite suppressant. It's safe for many people, but not for those with heart disease, uncontrolled blood pressure, glaucoma, an overactive thyroid, pregnancy or a history of substance misuse.

Phentermine is one of the oldest weight-loss medicines, and it's back in the conversation for a practical reason: many insurance plans won't pay for Wegovy or Zepbound until you've tried it first. That can feel like a hoop to jump through, and sometimes it is. But for the right person, phentermine is an inexpensive medicine that helps, and for the wrong person it's a bad idea. Here is how I'd sort that out.

**3 months**of phentermine is a common insurance requirement before a GLP-1 is covered

**5%**weight loss: the usual bar for whether a weight-loss medicine is working

**0.3%**of nearly 14,000 phentermine users had a heart event or died over up to 3 years, none among long-term users

## Why insurance often asks for phentermine first

This is called step therapy: a plan covers a costly medicine only after a cheaper one has been tried. GLP-1 medicines cost far more than generic phentermine, so many plans put phentermine first.

As an example, the prior authorization form for Wegovy and Zepbound from the US Family Health Plan, a TRICARE plan, asks whether you:

- Have a BMI of 30 or higher, or 27 to 29 with a weight-related condition such as high blood pressure or diabetes.
- Have been in a diet and behavior program for at least 6 months, and are still in it.
- Tried generic phentermine, or a similar older medicine, for 3 months without losing 5% of your starting weight. A documented reason you can't take it, or a bad reaction to it, also counts.

Approval lasts a year. To renew, adults need to have lost at least 5% of their starting weight on the full dose. Other plans have their own rules, so I'd always check yours. If phentermine works well for you, the step may also be the end of the road: some people reach their goal without needing a GLP-1.

Keep good records

Write down your starting weight, the date you started, your dose and any side effects. If you need a GLP-1 later, that record is what gets the prior authorization approved.

## How phentermine works

Phentermine is a stimulant related to amphetamine. It acts on the brain to reduce appetite and make you feel full sooner. The usual dose is one 37.5 mg tablet in the morning, before or 1 to 2 hours after breakfast; half a tablet is also an option. Taken late in the day, it can keep you awake. Because it can be misused, it's a Schedule IV controlled substance, and prescriptions are limited and tracked.

## Who it's for

The FDA label approves phentermine for adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as controlled high blood pressure, diabetes or high cholesterol. It's meant to be used together with a lower-calorie diet, exercise and behavior changes, not instead of them.

The label calls it a short-term medicine, for a few weeks. The American Gastroenterological Association's 2022 guideline also describes it as approved for 12 weeks, with longer use off-label. In practice, many doctors prescribe it longer for people who are doing well, and a large study of real-world patients (below) supports that. We'd decide on the length together.

## Who shouldn't take it

The label says not to use phentermine if you have:

- **Heart disease:** coronary artery disease, a past stroke, heart rhythm problems, heart failure or uncontrolled high blood pressure.
- **An overactive thyroid** (hyperthyroidism).
- **Glaucoma.**
- **A history of drug or alcohol misuse,** or a state of agitation.
- **Pregnancy or breastfeeding.**
- **Taken an MAO inhibitor** antidepressant in the last 14 days.
- **A past reaction** to stimulant medicines.

It also isn't recommended for children 16 or younger, together with other weight-loss medicines or serotonin-boosting antidepressants (SSRIs), or for people with severe kidney disease without a lower dose. If you have even mild high blood pressure or take insulin or other diabetes medicines, it can still be an option, but it needs closer follow-up, because blood pressure can rise and blood sugar medicines may need to come down.

## What the evidence shows

The evidence for phentermine is real but more modest than for the newer medicines.

- **The older trials** behind its approval found more weight loss than diet alone, but the FDA label itself describes the extra loss as a fraction of a pound a week, and the overall effect as limited.
- **The 2022 AGA guideline** suggests phentermine alongside lifestyle changes, based on lower-certainty evidence, and notes a lack of high-quality long-term data.
- **Combined with topiramate,** phentermine does much better. In a 28-week trial, the combination led to 8.5 to 9.2% weight loss, compared with 1.7% on placebo.
- **Longer-term use looked safe and effective** in a 2019 study of nearly 14,000 patients. People who took it continuously for more than a year had kept off more than 7% of their starting weight at 2 years, and there was no rise in heart events or deaths with longer use. It was an observational study, not a randomized trial, so it can't prove cause and effect.

| Medicine | Extra weight loss beyond placebo in the AGA review |
| --- | --- |
| Semaglutide (Wegovy) | 10.8% |
| Phentermine with topiramate (Qsymia) | 8.5% |
| Liraglutide (Saxenda) | 4.8% |
| Naltrexone with bupropion (Contrave) | 3.0% |
| Phentermine alone | Not ranked; less high-quality data |

So phentermine is a reasonable, low-cost first step, and the GLP-1 medicines in my [weight-loss medication guide](https://www.collinbennett.com/weight-loss-medications) are stronger options when it isn't enough.

## Common side effects

- **Dry mouth and an unpleasant taste.** Sip water through the day and chew sugar-free gum.
- **Trouble sleeping.** Take it first thing in the morning, and skip caffeine in the afternoon.
- **Restlessness, jitteriness, dizziness or headache.** These often ease after the first couple of weeks, and a lower dose helps.
- **A faster heart rate, palpitations and higher blood pressure.** I'd check both before you start and at every follow-up, and you can check at home.
- **Constipation or diarrhea.** Fiber, fluids and movement help.
- **Mood changes,** including irritability or feeling down, and changes in sex drive.

### Rare but serious

- **Pulmonary hypertension,** high pressure in the lungs' blood vessels, and **heart valve disease** have been reported rarely. Warning signs are new shortness of breath, chest pain, fainting or leg swelling.
- **Dependence,** especially at high doses or with long use. Don't take more than prescribed, and if it stops working, the answer is to stop it, not raise the dose.

## How I'd use it

1. **Screen**Your history, heart, blood pressure, pulse, thyroid, medicines and any history of substance use. I'd also check the state prescription monitoring database, as for any controlled medicine.
2. **Start**A low or standard dose in the morning, with a plan for eating, protein and strength training to protect muscle.
3. **Check**A visit within about a month for weight, blood pressure, pulse and side effects, then regularly after that.
4. **Decide**At about 3 months: if you've lost 5% or more and feel well, we can continue. If not, it isn't working, and for many people that's when a GLP-1 makes sense and insurance is more likely to cover it.

## When to call

- Chest pain, a racing or pounding heartbeat that won't settle, or fainting: call 911.
- New shortness of breath, trouble exercising, or swelling in your legs.
- Home blood pressure readings that stay higher than before you started.
- Insomnia, anxiety or mood changes that don't settle after the first couple of weeks.
- Feeling that you need more than the prescribed dose.
- You become pregnant or plan to.

## Common questions

### Why do I have to try phentermine before Wegovy or Zepbound?

Many insurance plans, including TRICARE plans, won't cover Wegovy or Zepbound until you've tried a cheaper medicine such as phentermine for about 3 months, unless you have a reason not to take it.

### How does phentermine work?

Phentermine is an inexpensive, once-daily appetite suppressant.

### Who should not take phentermine?

People with heart disease, uncontrolled blood pressure, glaucoma, an overactive thyroid, pregnancy or a history of substance misuse shouldn't take it.

**Related guides from Dr. Bennett:** [weight-loss medications](https://www.collinbennett.com/weight-loss-medications), [high blood pressure](https://www.collinbennett.com/high-blood-pressure), and [prediabetes and type 2 diabetes](https://www.collinbennett.com/prediabetes-type-2-diabetes).

Sources: Adipex-P (phentermine hydrochloride) prescribing information. Teva Pharmaceuticals, via Drugs.com. [drugs.com](https://www.drugs.com/pro/adipex-p.html). US Family Health Plan. Wegovy and Zepbound prior authorization request form (TRICARE). January 2026. [usfhp.s3.amazonaws.com](https://usfhp.s3.amazonaws.com/files/resources/wegovy-updated-01-28-2026.pdf). Grunvald E, et al. AGA clinical practice guideline on pharmacological interventions for adults with obesity. *Gastroenterology*. 2022, as summarized in *Healio*. [healio.com](https://www.healio.com/news/gastroenterology/20221215/aga-releases-first-guideline-ranking-most-effective-antiobesity-medications). Aronne LJ, Wadden TA, Peterson C, Winslow D, Odeh S, Gadde KM. Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults. *Obesity*. 2013;21(11):2163–2171. Lewis K, Arterburn D, et al. Safety and effectiveness of longer-term phentermine use: clinical outcomes from an electronic health record cohort. *Obesity*. 2019, as summarized by Kaiser Permanente Washington Health Research Institute. [kpwashingtonresearch.org](https://www.kpwashingtonresearch.org/news-and-events/blog/2019/mar-2019/Using_phentermine_for_weight_loss_more_than_3_months_seems_safe_and_effective).

## Keep reading

[See every health note →](https://www.collinbennett.com/notes)

[Chronic managementWeight-loss medications: what to know before you startWegovy, Zepbound, the new weight-loss pills and more: how they work, how much weight people lose, the real risks, how I'd run a weight management visit, dosing schedules and how to inject.](https://www.collinbennett.com/weight-loss-medications)[Chronic managementHigh blood pressure: what the numbers mean and how I'd treat itWhat your numbers mean under the 2025 guideline, how to check at home the right way, what lowers blood pressure without pills, how the medicines compare, and their common side effects.](https://www.collinbennett.com/high-blood-pressure)
